Cleveland-based company develops ‘completely different’ rapid COVID-19 diagnostics test


CLEVELAND, Ohio (WOIO) – A Cleveland-based technology company partnered with Purdue University to develop a rapid diagnostic test to detect numerous pathogens, including the molecule that causes COVID-19.

The technology from the Purdue and IdentifySensors Biologics collaboration can also be modified to detect influenza, Zika, HIV/AIDS, hepatitis C, chickenpox, and more.

“This test can be done fast, it’s accurate and can be done at home,” IdentifySensors CEO Gregory Hummer, MD, said.

Click here to read the complete story.

Story excerpt provided by Cleveland 19 News.

Written by Chris Anderson.

Originally published November 2, 2020.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: